Literature DB >> 15844881

Studies into the stereoselectivity of tartrate-derived dienophiles.

Wei-Der Lee1, Kwangho Kim, Gary A Sulikowski.   

Abstract

[reaction: see text] Diels-Alder reactions of 1-(tert-butyldimethylsiloxy)-1,3-butadiene (3) with three C2 symmetric dienophiles derived from tartaric acid have been examined. Complementary diastereoselectivity is observed depending on the nature of the 1,2-diol protecting group incorporated in these dienophiles.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15844881     DOI： 10.1021/ol050105c

Source DB:  PubMed          Journal:  Org Lett        ISSN： 1523-7052            Impact factor:   6.005


  6 in total

1.  Assignment and stereocontrol of hibarimicin atropoisomers.

Authors:  Ian M Romaine; Jonathan E Hempel; Ganesh Shanmugam; Hiroshi Hori; Yasuhiro Igarashi; Prasad L Polavarapu; Gary A Sulikowski
Journal:  Org Lett       Date:  2011-08-03       Impact factor: 6.005

2.  Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1.

Authors:  Brian B Liau; Benjamin C Milgram; Matthew D Shair
Journal:  J Am Chem Soc       Date:  2012-09-26       Impact factor: 15.419

3.  Synthesis of an A'B' Precursor to Angelmicin B: Product Diversification in the Suárez Lactol Fragmentation.

Authors:  Jialiang Li; Louis Todaro; David R Mootoo
Journal:  European J Org Chem       Date:  2011-09-07

4.  Gram-scale synthesis of the A'B'-subunit of angelmicin B.

Authors:  Benjamin C Milgram; Brian B Liau; Matthew D Shair
Journal:  Org Lett       Date:  2011-11-15       Impact factor: 6.005

5.  Synthesis of the AB subunit of angelmicin B through a tandem alkoxy radical fragmentation-etherification sequence.

Authors:  Jialiang Li; Louis J Todaro; David R Mootoo
Journal:  Org Lett       Date:  2008-03-07       Impact factor: 6.005

6.  Synthesis and Biological Evaluation of Diversified Hamigeran B Analogs as Neuroinflammatory Inhibitors and Neurite Outgrowth Stimulators.

Authors:  Ruo-Xin Li; Rui Han; Guo-Jie Wu; Fu-She Han; Jin-Ming Gao
Journal:  Mar Drugs       Date:  2020-06-11       Impact factor: 5.118
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.